Related Experiment Video
Updated: Jun 16, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
A year of successful cancer vaccines points to a path forward
Michael A Morse1, Michael Whelan
1Duke University Medical Center, Durham, NC 27710, USA. morse004@mc.duke.edu
Abstract:
Results from recent clinical trials of the therapeutic vaccines sipuleucel-T (Dendreon Corp), PROSTVAC-VF-TRICOM (National Cancer Institute/BN ImmunoTherapeutics Inc) and BiovaxID (Biovest International Inc) are highlighted. These data support the further development of such vaccines, and provide guidance for the development of improved agents and protocols for the use of therapeutic vaccination to treat cancer.
Insights
Recent clinical trials for therapeutic cancer vaccines like sipuleucel-T show promise. These findings support further development of improved vaccination strategies for cancer treatment.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Therapeutic cancer vaccines represent a promising approach to harnessing the immune system for cancer treatment.
- Several novel therapeutic vaccines have undergone clinical evaluation.
Purpose of the Study:
- To highlight results from recent clinical trials of therapeutic cancer vaccines.
- To provide guidance for the development of improved therapeutic vaccination strategies.
Main Methods:
- Review of clinical trial data for sipuleucel-T, PROSTVAC-VF-TRICOM, and BiovaxID.
- Analysis of outcomes to inform future vaccine development.
Main Results:
- Clinical trial data for sipuleucel-T, PROSTVAC-VF-TRICOM, and BiovaxID demonstrate the potential of therapeutic cancer vaccines.
- The results support the continued investigation and advancement of these agents.
Conclusions:
- The data underscore the viability of therapeutic vaccination as a cancer treatment modality.
- Further research and optimized protocols are essential for enhancing the efficacy of cancer vaccines.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

